# A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

> **NCT05362903** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1868 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **OTHER:** Inclisiran

## Key facts

- **NCT ID:** NCT05362903
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-31
- **Primary completion:** 2025-11-28
- **Final completion:** 2025-11-28
- **Target enrollment:** 1868 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362903, "A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05362903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*